|
Riemser
Riemser Arzneimittel AG
RIEMSER Arzneimittel AG is a medium-sized pharmaceutical company engaging in research and headquartered in the West Pomeranian town of Greifswald - Island of Riems. The stockholding company (AG) operates several branches in Germany and produces advanced substances and medicinal products to be applied in most different areas for both humans and animals. The preparations are sold globally. The company was founded as RIEMSER Tierarzneimittel GmbH in 1990 and privatised in 1992. Since then, turnover has risen from one million euros to 44 million euros in 2005. The number of employees increased from 30 to 380 within the same period.
The company is boosting its intensive research work by a budget of five million euros in 2006. The Human segment focuses on biotechnological medicinal products for treating tumourous and immunological diseases. The Veterinary segment develops vaccines and immunoglobulins. Partners of the research and development department are well-known research institutes and universities in Germany and Europe. Institutes of the medical faculties of the universities of Rostock and Greifswald as well as the renowned Friedrich-Löffler-Institut Insel Riems (FLI) are involved in the research work in the federal state of Mecklenburg–West Pomerania. |
|
